Search - tctmd.com

Displaying 261 - 280 of 303

Sort: Relevancy | Date

News Conference News

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

November 17, 2011

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

News Industry News

Paclitaxel-coated balloon angioplasty demonstrates superior results

November 10, 2011

News Daily News

DES Associated with Less Downstream Lesion Development than BMS

L.A. McKeown

November 04, 2011

News Daily News

First DES for Above-the-Knee Vascular Disease on the Horizon

L.A. McKeown

October 18, 2011

News Industry News

Boston Scientific Begins Clinical Trial Enrollment for OMEGA™ Platinum Chromium Stent System

October 05, 2011

News Daily News

Clinical Variables Added to Syntax Score Increases Predictive Ability

L.A. McKeown

September 30, 2011

News Daily News

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Leah Lawrence

September 29, 2011

News Daily News

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

September 14, 2011

News Daily News

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Jason Kahn

September 12, 2011

News Daily News

Drug-Eluting Balloons Show ‘Impressive’ Results in Below-the-Knee Lesions

Jason Kahn

September 08, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Conference News

Long-term Antiplatelet Therapy: All Risk, No Benefit

August 30, 2011

News Daily News

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

Leah Lawrence

August 23, 2011

News Daily News

No Apparent Advantage for Everolimus vs. Paclitaxel Stents in Diabetic Patients

L.A. McKeown

August 19, 2011

News Daily News

ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics

Caitlin E. Cox

August 03, 2011

News Daily News

DES Show Advantage over BMS for Heart Transplant Complication

L.A. McKeown

July 01, 2011

News Daily News

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Caitlin E. Cox

June 24, 2011

News Daily News

Cordis Announces Plans to Discontinue Cypher Stents, Drop Nevo Development

L.A. McKeown

June 15, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

Advertisement

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

Paclitaxel-coated balloon angioplasty demonstrates superior results

DES Associated with Less Downstream Lesion Development than BMS

First DES for Above-the-Knee Vascular Disease on the Horizon

Boston Scientific Begins Clinical Trial Enrollment for OMEGA™ Platinum Chromium Stent System

Clinical Variables Added to Syntax Score Increases Predictive Ability

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Drug-Eluting Balloons Show ‘Impressive’ Results in Below-the-Knee Lesions

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

Long-term Antiplatelet Therapy: All Risk, No Benefit

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

No Apparent Advantage for Everolimus vs. Paclitaxel Stents in Diabetic Patients

ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics

DES Show Advantage over BMS for Heart Transplant Complication

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Cordis Announces Plans to Discontinue Cypher Stents, Drop Nevo Development

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content